This inventor holds 2 USPTO granted patents and 5 published patent applications. Top assignee: Prelude Therapeutics Incorporated. Active years: 2023-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2024
Title: Ryan Holmes: Innovator in Pharmaceutical Development
Introduction
Ryan Holmes is a notable inventor based in Wilmington, DE (US), recognized for his contributions to the field of pharmaceuticals. With a focus on innovative compounds, he has made significant strides in the development of CDK inhibitors.
Latest Patents
Holmes holds two patents related to CDK inhibitors and their use as pharmaceuticals. The disclosures are directed to compounds of Formula I, which include pharmaceutical compositions comprising these compounds. Additionally, methods of their use and preparation are also described in his patents.
Career Highlights
Ryan Holmes is currently associated with Prelude Therapeutics Incorporated, where he applies his expertise in pharmaceutical innovation. His work has been instrumental in advancing the understanding and application of CDK inhibitors in medical treatments.
Collaborations
Some of his notable coworkers include Xiaowei Wu and Andrew W. Buesking, who collaborate with him in the pursuit of groundbreaking pharmaceutical research.
Conclusion
Ryan Holmes exemplifies the spirit of innovation in the pharmaceutical industry, particularly through his work on CDK inhibitors. His contributions continue to shape the future of medical treatments and drug development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile